In Response to Precision Medicine: Current Subcellular Targeting Strategies for Cancer Therapy

Zheng Li1,2, Jianhua Zou1,2, Xiaoyuan Chen1,2,3,4

  • 1Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore, 119074, Singapore.

Insights

Subcellular targeted cancer therapy utilizes molecules and nanomaterials to target specific organelles, offering new anticancer treatment strategies. This approach aims to enhance therapeutic efficacy by exploiting organelle properties for tumor elimination.

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Nanotechnology

Background:

  • Subcellular targeted cancer therapy is a rapidly advancing field with significant clinical potential.
  • Targeting specific organelles offers a novel approach to cancer treatment by exploiting their unique functions and vulnerabilities.

Purpose of the Study:

  • To summarize current strategies for subcellular organelle-targeted cancer therapy.
  • To review both molecule- and nanomaterial-based approaches for targeting mitochondria, lysosomes, endoplasmic reticulum, and the nucleus.

Main Methods:

  • Review of targeting strategies based on molecular and nanomaterial delivery systems.
  • Analysis of therapeutic modalities including phototherapy, chemotherapy, radiotherapy, immunotherapy, and combination therapies.
  • Discussion of materials designed based on organelle-specific properties and mechanisms.

Main Results:

  • Two main targeting strategies for four key subcellular organelles are detailed.
  • Various therapeutic approaches, including combination therapies, are presented.
  • Materials are designed to induce organelle dysfunction or structural destruction for tumor elimination.

Conclusions:

  • Organelle-targeting cancer therapies hold promise for enhanced efficacy.
  • Challenges in current organelle-targeting strategies are identified.
  • A future paradigm for improved cancer treatment through organelle targeting is envisioned.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
630
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.1K